Furthermore in this study, LRRTM3 SNP multilocus genotypes (MLGs) were shown to have statistical interactions with PLAU, previously implicated in AD risk and Aβ levels [16], as well as CDC2 and ACE in conferring AD risk. The gene discussed is PLAU; the disease is Alzheimer disease.